Patents by Inventor Maximilian REINHARDT

Maximilian REINHARDT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230235041
    Abstract: The present disclosure relates to methods for treating Thyroid Eye Disease (e.g., Graves' Orbitopathy) using Interleukin (IL)-17 antagonists, e.g., secukinumab. Also disclosed herein are IL-17 antagonists, e.g., IL-17 antibodies, such as secukinumab, for treating patients having Thyroid Eye Disease (e.g., Graves' Orbitopathy), as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.
    Type: Application
    Filed: June 23, 2021
    Publication date: July 27, 2023
    Inventors: Gerard BRUIN, Georges Jean KAHALY, Meryl MENDELSON, Maximilian REINHARDT
  • Publication number: 20220403018
    Abstract: The present disclosure relates to methods for treating lichen planus (e.g., lichen planopilaris, mucosal lichen planus, cutaneous lichen planus) using Interleukin (IL)-17 antagonists, e.g., secukinumab. Also disclosed herein are IL-17 antagonists, e.g., IL-17 antibodies, such as secukinumab, for treating patients having lichen planus (e.g., lichen planopilaris, mucosal lichen planus, cutaneous lichen planus), as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.
    Type: Application
    Filed: December 4, 2020
    Publication date: December 22, 2022
    Inventors: Deborah Lynn KEEFE, Elisa MUSCIANISI, Maximilian REINHARDT, Xiaoling WEI, Ruquan (Ryan) YOU